glp-1 and weight watchers Goes All-In on GLP-1s With App Overhaul Weight Watchers GLP-1 Cookbook

Without generic competition, manufacturers can maintain high prices

While these medications are not absolutely contraindicated in these groups, the decision to prescribe should involve thorough discussion of individual circumstances, close monitoring, and consideration of alternative treatments

Medical providers need a broad spectrum of solutions to address the needs of customers and that includes those with weight challenges

In STEP-1 (Wilding et al., NEJM 2021), 68 weeks of once-weekly 2.4 mg semaglutide plus lifestyle intervention produced a mean body-weight reduction of about 15%, versus about 2.4% with placebo a large, clinically meaningful, well-replicated effect

This is one reason many endocrinologists prefer injectable GLP-1 medications for patients on thyroid hormone replacement